Could be a number of things. Probably sneaky accumulation, but it could also be fund managers ramping the share price before the end of year to increase their bonuses. Oh cynical me.
However, considering that a month ago that We signed the largest contract to date, being another of the top five medical schools/medical groups in the US (making three out of five) it makes sense. Mayo will contribute to revenue for the first time this HY. Likely yoy profit will be up 30-50%, margins passing the 50% level.
in an environment of falling profitability PME will be a stand-out.
PME Price at posting:
$11.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)